235 related articles for article (PubMed ID: 25120085)
21. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
[TBL] [Abstract][Full Text] [Related]
22. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
23. Combination of eosinophil percentage and high-sensitivity C-reactive protein predicts in-hospital major adverse cardiac events in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Ye L; Bai HM; Jiang D; He B; Wen XS; Ge P; Zhang DY
J Clin Lab Anal; 2020 Sep; 34(9):e23367. PubMed ID: 32441412
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Value of Right Ventricular Function Assessed by Echocardiography in Patients Presenting With a First Acute ST Elevation Myocardial Infarction Treated By Primary PCI.
Zamfir D; Pitic D; Tamaşescu G; Onciul S; Tăutu O; Angelescu C; Onuţ R; Stoian M; Dorobanţu M
Rev Med Chir Soc Med Nat Iasi; 2016; 120(4):824-33. PubMed ID: 30137954
[TBL] [Abstract][Full Text] [Related]
25. The burden of major adverse cardiac events in patients with coronary artery disease.
Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
[TBL] [Abstract][Full Text] [Related]
26. Cardiac troponin elevation pattern in patients undergoing a primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: characterization and relationship with cardiovascular events during hospitalization.
Buber J; Laish-Farkash A; Koren-Morag N; Fefer P; Segev A; Hod H; Matetzky S
Coron Artery Dis; 2015 Sep; 26(6):503-9. PubMed ID: 26061436
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI.
Méndez-Eirín E; Flores-Ríos X; García-López F; Pérez-Pérez AJ; Estévez-Loureiro R; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Calviño-Santos RA; Vázquez Rodríguez JM; Vázquez-González N; Castro-Beiras A
Rev Esp Cardiol (Engl Ed); 2012 Mar; 65(3):227-33. PubMed ID: 22281285
[TBL] [Abstract][Full Text] [Related]
28. Comparison of infarct-related artery vs multivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease: analysis from Korea Acute Myocardial Infarction Registry.
Lee HW; Hong TJ; Yang MJ; An SG; Oh JH; Choi JH; Lee HC; Cha KS; Hong JY;
Cardiol J; 2012; 19(3):256-66. PubMed ID: 22641544
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
30. The High-Sensitivity C-Reactive Protein to Prealbumin Ratio Predicts Adverse Cardiovascular Events after ST-Elevation Myocardial Infarction.
Ren H; Zhao L; Liu Y; Tan Z; Luo G; Deng X
Heart Surg Forum; 2021 Feb; 24(1):E153-E157. PubMed ID: 33635266
[TBL] [Abstract][Full Text] [Related]
31. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
[TBL] [Abstract][Full Text] [Related]
32. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
[TBL] [Abstract][Full Text] [Related]
33. [The predictive value of risk scoring system in myocardial infarction in long-term prognosis of patients referred to direct percutaneous coronary intervention].
Zhao MZ; Hu DY; Li WH; Chen XY; Xu YY
Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):584-7. PubMed ID: 15355662
[TBL] [Abstract][Full Text] [Related]
34. The value of serum Sema4D level in predicting the prognosis of patients with acute ST-segment elevation myocardial infarction and with high thrombus burden.
Bai J; Chen L; Xu L; Zhang Q; Liu J; Zheng K
BMC Cardiovasc Disord; 2023 May; 23(1):230. PubMed ID: 37138227
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 30-Day MACE between Immediate versus Staged Complete Revascularization in Acute Myocardial Infarction with Multivessel Disease, and the Effect of Coronary Lesion Complexity.
Doğan C; Bayram Z; Çap M; Özkalaycı F; Unkun T; Erdoğan E; Uslu A; Acar RD; Guvendi B; Akbal ÖY; Karagöz A; Hakgor A; Karaduman A; Uysal S; Aykan A; Kaymaz C; Özdemir N
Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30781429
[No Abstract] [Full Text] [Related]
36. Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.
De Luca G; Sauro R; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Palmieri V; Serino V; Rosato G; Suryapranata H; Di Lorenzo E
Diab Vasc Dis Res; 2015 Sep; 12(5):306-14. PubMed ID: 26150193
[TBL] [Abstract][Full Text] [Related]
37. A comparison of direct versus conventional stenting in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
Isik T; Ayhan E; Uyarel H; Ergelen M; Cicek G; Osmonov D; Turkkan C; Turer A; Ghannadian B; Eren M
Coron Artery Dis; 2012 Aug; 23(5):348-53. PubMed ID: 22566098
[TBL] [Abstract][Full Text] [Related]
38. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
[TBL] [Abstract][Full Text] [Related]
39. The impact of distal embolization and distal protection on long-term outcome in patients with ST elevation myocardial infarction randomized to primary percutaneous coronary intervention--results from a randomized study.
Lønborg J; Kelbæk H; Helqvist S; Holmvang L; Jørgensen E; Saunamäki K; Kløvgaard L; Kaltoft A; Bøtker HE; Lassen JF; Thuesen L; Terkelsen CJ; Kofoed KF; Clemmensen P; Køber L; Engstrøm T
Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):180-8. PubMed ID: 25013089
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Møgelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Jensen JS
Am J Cardiol; 2012 Feb; 109(4):492-6. PubMed ID: 22105783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
